Ilika appoints Panmure Liberum Limited as its Nominated Adviser and Joint Broker

Ilika plc

Ilika plc (LON:IKA), an independent global expert in solid-state battery technology, has announces that, following the completion of the all-share merger between Liberum Capital Limited and Panmure Gordon Group Limited, the Company has changed its Nominated Adviser and Joint Broker to Panmure Liberum Limited with immediate effect.

Ilika is a pioneer in a ground-breaking solid state battery technology designed to meet the specific demands of a wide range of applications in MedTech, Industrial IoT, Electric Vehicles and Consumer Electronics.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika completes PRIMED programme with improved Goliath battery performance

Ilika has completed its £3 million PRIMED programme, reporting improved energy density, charging, power, cycle life and thermal stability for its 10Ah Goliath solid-state battery cells, alongside new commercial opportunities in defence, e-bikes and other applications.

Ilika to present UK-developed quasi-solid-state cell technology at Faraday Event

Ilika will present its UK-developed quasi-solid-state cell technology at The Faraday Institution’s Next Frontiers in Energy Storage event on Tuesday 8 September.

Ilika targets MedTech adoption with Stereax solid-state batteries

Ilika is targeting medical device and IoT applications with its Stereax miniature solid-state batteries, supported by a manufacturing and commercialisation agreement with Cirtec Medical.

Ilika confirms AGM date and Annual Report posting

Ilika has given notice of its 2026 Annual General Meeting and said its annual report and AGM notice will be available shortly.

Ilika targets medical device opportunities with Stereax at MedTech Ireland

Ilika’s Stereax technology will be presented at MedTech Ireland 2026 as the company targets further opportunities in active implanted medical devices.

Search